ライフサイエンスコーパス: echocardiography

1 instituted by Medicare (CT, nuclear imaging, echocardiography).

2 g completion of anthracycline therapy (29.7% echocardiography).

3 ly relevant 6MWT and LV mass regression than echocardiography.

4 -time integral was measured by transthoracic echocardiography.

5 Cardiac function was assessed by echocardiography.

6 esting, and exercise electrocardiography and echocardiography.

7 ography, and three-dimensional transthoracic echocardiography.

8 iac function was measured using non-invasive echocardiography.

9 owing incremental benefit over transthoracic echocardiography.

10 red with non-treated CKD mice as measured by echocardiography.

11 gic transformation, or high-risk features on echocardiography.

12 diac function were assessed by histology and echocardiography.

13 nostic uncertainty following transesophageal echocardiography.

14 ar function was evaluated with transthoracic echocardiography.

15 tion with LVEF of 40% or less as measured by echocardiography.

16 nt transthoracic two-dimensional and Doppler echocardiography.

17 nalyzed using 2-dimensional speckle tracking echocardiography.

18 s 5.34+/-1.19 [n=6]; P=0.004) as assessed by echocardiography.

19 mbolism as that detected by both LGE CMR and echocardiography.

20 magnetic resonance imaging and 3-dimensional echocardiography.

21 lar (LV) structure/function was monitored by echocardiography.

22 ects were recorded on electrocardiography or echocardiography.

23 hood after staged surgical palliations using echocardiography.

24 alve and cardiac function were determined by echocardiography.

25 therapy, assessed by a second transthoracic echocardiography.

26 tients underwent comprehensive pre-procedure echocardiography.

27 eks, and cardiac function was assessed using echocardiography.

28 ve due to intermittent bacteremia and normal echocardiography.

29 cular flow reserve (FR) on dobutamine stress echocardiography.

30 -13 ammonia positron emission tomography and echocardiography.

31 nvasively with a Swan-Ganz catheter and with echocardiography.

32 as observed in 3.3% of patients at follow-up echocardiography.

33 ventricular (RV) function was determined by echocardiography.

34 hy, computed tomography calcium scoring, and echocardiography.

35 puted tomography calcium scoring, and repeat echocardiography.

36 thickening was observed in Fabry rats using echocardiography.

37 ressure <40 mm Hg, and normal RV function by echocardiography.

38 ailure and pericardial effusion diagnosed on echocardiography.

39 and healthy participants (N = 44) underwent echocardiography.

40 fulfilled diagnostic criteria on CMR but not echocardiography.

41 try patients were screened preoperatively by echocardiography.

42 morphology and function were examined using echocardiography.

43 tion, as diagnosed by using semiquantitative echocardiography.

44 ventional and 2-dimensional speckle-tracking echocardiography.

45 ing catheters are effectively evaluated with echocardiography.

46 pressure (PASP) was determined using Doppler echocardiography.

47 women) who underwent proteomic profiling and echocardiography.

48 underwent cardiopulmonary exercise test and echocardiography 1 day before transcatheter VSD closure

49 diac function and remodeling was assessed by echocardiography 10 weeks after surgery.

50 receiving APT at the time of transesophageal echocardiography (10.2% versus 0% if OAC at the time of

51 cology recommend consideration of the use of echocardiography 6 to 12 months after completion of anth

52 ndex (LVMI) (indexed to body surface area on echocardiography, 67 patients).

53 The greater the downstream stress echocardiography abnormality caused by a stenosis, the g

54 nts underwent repeat computed tomography and echocardiography after 2 years.

55 ice were subjected to treadmill exercise and echocardiography after treatment to determine maximal ox

56 Stress echocardiography alone is not reliable in screening LT p

57 Transesophageal echocardiography and balloon interrogation identified 60

58 PH and eLAP were determined by Doppler echocardiography and by tissue Doppler imaging, respecti

59 Strain echocardiography and cardiac biomarkers were obtained be

60 EI has not been evaluated by concurrent echocardiography and cardiac catheterization and traditi

61 Anatomic imaging tools such as echocardiography and cardiac CT or CT angiography are th

62 Characteristic patterns of echocardiography and cardiac magnetic resonance can stro

63 nts underwent 2-dimensional speckle tracking echocardiography and cardiovascular magnetic resonance i

64 Conclusions Using simultaneous echocardiography and catheterization in the largest stud

65 ern was determined at baseline transthoracic echocardiography and classified as follows: (1) HG; (2)

66 Methods Echocardiography and CMR were performed in 1119 patients

67 ll patients had pre-valve intervention 6MWT, echocardiography and CMR with 4D flow.

68 Patients in the routine strategy underwent echocardiography and CMR, whereas those assigned to sele

69 At PN80 cardiac function was evaluated by echocardiography and Doppler analysis at rest and follow

70 Echocardiography and Doppler ultrasound assessments for

71 e study, individuals with SCA underwent CMR, echocardiography and exercise test.

72 hesia and with guidance from transesophageal echocardiography and fluoroscopy.

73 (BDL)-induced liver fibrosis, by monitoring echocardiography and intracardiac pressure-volume relati

74 Recent advances in echocardiography and magnetic resonance imaging have ena

75 ng myocardial infarction, as demonstrated by echocardiography and magnetic resonance imaging.

76 We performed echocardiography and maximal exercise tests at sea level

77 spheres and compared the results to contrast echocardiography and MIGET-determined gas exchange shunt

78 nding zone with simultaneous transesophageal echocardiography and pulmonary venography to confirm def

79 veloped precapillary PH, as measured by both echocardiography and right/left heart catheterization.

80 quantitative real-time myocardial perfusion echocardiography and speckle tracking echocardiography i

81 Weekly echocardiography and terminal haemodynamic measurements

82 The American Society of Echocardiography and the European Association of Cardiov

83 Using the 2016 American Society of Echocardiography and the European Association of Cardiov

84 was to evaluate the 2016 American Society of Echocardiography and the European Association of Cardiov

85 ivity and specificity of American Society of Echocardiography and the European Association of Cardiov

86 The agreement between echocardiography and the pulmonary artery catheter was m

87 e obtained by real-time myocardial perfusion echocardiography and their value in preventing left vent

88 post-IR systolic dysfunction (by ultrasound echocardiography) and increased fibrosis in mice.

89 t invasive cardiopulmonary exercise testing, echocardiography, and assessment of microvascular functi

90 vasive hemodynamic measures, transesophageal echocardiography, and blood analysis.

91 omputed tomography imaging, cineangiography, echocardiography, and electrocardiograms.

92 al shunt with 25-um microspheres to contrast echocardiography, and gas exchange shunt measured by the

93 e performance was assessed with fluoroscopy, echocardiography, and histology at 30 (n=2), 60 (n=3), a

94 siological and calcium transient recordings, echocardiography, and radiotelemetry monitoring, we foun

95 assessed with 2-dimensional speckle-tracking echocardiography, and region-specific analysis to compar

96 Heart function was examined by echocardiography, and related cellular and molecular mec

97 At week 4, treadmill testing, echocardiography, and right heart catheterization were p

98 tandard biological parameters, transthoracic echocardiography, and right heart catheterization.

99 routine blood investigation, two-dimensional echocardiography, and serum BDNF estimation.

100 cal window (EMW) negativity, as derived from echocardiography, and symptomatic versus asymptomatic st

101 trast-enhanced two-dimensional transthoracic echocardiography, and three-dimensional transthoracic ec

102 n cardiac structure and function assessed by echocardiography are lacking.Objectives: In a prespecifi

103 eritability estimates of LV mass measured by echocardiography are lower.

104 oreal membrane oxygenation macrocirculation, echocardiography, arterial blood gases, and microcircula

105 izes the importance of Doppler transthoracic echocardiography as a predictor of outcomes among critic

106 ily based on the modified Duke criteria with echocardiography as the first-line imaging modality.

107 pericardial effusion; and used transthoracic echocardiography as the reference standard.

108 LV remodeling was assessed by echocardiography as well as histological and molecular p

109 inpatients undergoing clinical transthoracic echocardiography at 3 New York City hospitals were studi

110 ere prospectively evaluated by 2-dimensional echocardiography at baseline and at 1, 3, 5, 7, 9, and 1

111 ured, and the aortic valve was studied using echocardiography at each visit.

112 ed design, 12 healthy participants underwent echocardiography at rest and during submaximal exercise

113 aged 66-90 years, free of HF, who underwent echocardiography at the fifth study visit (June 8, 2011,

114 LV structure and function were evaluated by echocardiography at Y25.

115 c peptide) assessment during supine exercise echocardiography (baseline and peak exercise).

116 c function was assessed non-invasively using echocardiography before and after 2 weeks of daily pacin

117 PH), with ventilation-perfusion scanning and echocardiography being the initial diagnostic tests if C

118 tients had any type of cardiac surveillance (echocardiography, BNP, or cardiac imaging) in the year f

119 use of non-invasive imaging methods such as echocardiography, bone scintigraphy and cardiovascular M

120 Automated interpretation of echocardiography by deep neural networks could support c

121 Patients underwent echocardiography, cardiac magnetic resonance imaging, ex

122 She underwent electrocardiography, echocardiography, cardiac MRI with and without administr

123 ation, electrocardiography, laboratory test, echocardiography, cardiac MRI, and coronary CT and/or in

124 All participants underwent echocardiography, cardiopulmonary exercise testing, 6-mi

125 ed on other data sets, including human fetal echocardiography, chick embryonic heart ultrasound image

126 In December 2019, our institution's echocardiography clinical practice committee approved us

127 Transesophageal echocardiography confirms procedural success on follow-u

128 between groups except for higher spontaneous echocardiography contrast in the OAC group.

129 Spontaneous echocardiography contrast pre-LAAC associated with enhan

130 Spontaneous echocardiography contrast pre-LAAC was associated with a

131 procedure were analyzed by a consortium of 2 echocardiography core laboratories.

132 nical standard evaluation (metabolic status, echocardiography, coronary computed tomography angiograp

133 ond conventional imaging techniques, such as echocardiography, CT and cardiac magnetic resonance, nov

134 e laboratory tests, physical examination and echocardiography data were collected.

135 sing pulmonary pressures within the National Echocardiography Database of Australia cohort (n = 313,4

136 ies and divided into the American Society of Echocardiography DD groups.

137 Both transthoracic and transesophageal echocardiography delineate vegetation location and size,

138 Echocardiography demonstrated that Cfz led to a signific

139 We used a novel echocardiography-derived index of LV stiffness to compar

140 Echocardiography-derived pulmonary artery systolic press

141 systolic function (LV ejection fraction and echocardiography-derived strains) was improved, as was n

142 nts of blood flow are scarcely used in fetal echocardiography due to technical assumptions and issues

143 ial structure and function were evaluated by echocardiography, ECG, and in Langendorff-perfused heart

144 g a 48 cardiomyopathy-associated gene-panel, echocardiography, endomyocardial biopsies, and Holter mo

145 of agreement using 2009 American Society of Echocardiography/European Association of Echocardiograph

146 We collected a series of transthoracic echocardiography examinations performed between July 201

147 C or sham surgery followed by serial in vivo echocardiography for 14 weeks.

148 left ventricular ejection fraction (LVEF) by echocardiography for a selective use of CMR after ST-seg

149 strain may increase the diagnostic yield of echocardiography for ARVC.

150 absorptiometry (DEXA) for body composition, echocardiography for cardiac structure and function, int

151 tration during cardiac arrest, point-of-care echocardiography for intra-arrest prognostication, cardi

152 sonance (CMR) imaging is more sensitive than echocardiography for the detection of intracardiac throm

153 Repeat echocardiography for trivial/mild, mild-to-moderate, and

154 years [3-12 years]) underwent 3-dimensional echocardiography from 2014 to 2017 and compared with 65

155 antly different between CMR-FT and the three echocardiography gating methods (p > 0.05 for all).

156 were monitored by advanced speckle tracking echocardiography, gene expression analysis and immunohis

157 expanded on the standard American Society of Echocardiography grading scheme.

158 y guided revascularization (n=154) or stress echocardiography-guided revascularization (n=152) of the

159 occurred in 21 (14%) patients of the stress echocardiography-guided revascularization group and 22 (

160 l infarction and multivessel disease, stress echocardiography-guided revascularization may not be sig

161 an Heart Association and American Society of Echocardiography guidelines recommend assessing several

162 of Echocardiography/European Association of Echocardiography guidelines, but reproducibility of 2016

163 vere MR according to the American Society of Echocardiography guidelines.

164 Agitated saline contrast echocardiography had high sensitivity but low specificit

165 g adverse events and by electrocardiography, echocardiography, haematological testing, urinalysis, an

166 Traditional diagnostic techniques, including echocardiography, have poor sensitivity for diagnosing c

167 myocardial remodeling was assessed by serial echocardiography, histological and molecular analyses.

168 Among US veterans referred for echocardiography, HIV/HCV coinfection was not associated

169 elop B-lines upon submaximal exercise stress echocardiography; however, whether exercise-induced pulm

170 nst post-procedural clinical fluoroscopy and echocardiography images.

171 phageal echocardiogram but used intracardiac echocardiography imaging of the appendage from the right

172 eal echocardiogram screening or intracardiac echocardiography imaging of the appendage in DOAC compli

173 eal echocardiogram screening or intracardiac echocardiography imaging of the appendage; with low risk

174 Transthoracic echocardiography imaging was performed to measure cardia

175 fusion echocardiography and speckle tracking echocardiography imaging.

176 emodeling was characterized by transthoracic echocardiography in 1292 patients with significant secon

177 008 to 42.7% in 2018 (25.6% in 2008 to 40.5% echocardiography in 2018).

178 ements showed good overall agreement with 2D echocardiography in 51 cases with paired data (intra-cla

179 echocardiography, including transesophageal echocardiography in 74% of the cases.

180 ac damage was assessed using high-resolution echocardiography in ampicillin-rescued mice 3 months aft

181 he LV relaxation velocities (e') measured by echocardiography in both internal and external test sets

182 pective multicenter study was conducted with echocardiography in consecutive patients with E. faecali

183 The sensitivity of stress echocardiography in detecting significant CAD was 37%.

184 CT) is emerging as an adjunctive modality to echocardiography in the evaluation of infective endocard

185 outine use of 2-dimensional speckle tracking echocardiography in the evaluation of young patients wit

186 t changes in cardiac function as measured by echocardiography in the Grb14-knockdown mice fed a high-

187 herosclerosis were assessed using histology, echocardiography, in vivo electrophysiology, immunofluor

188 tation, using 2-dimensional speckle tracking echocardiography, in young patients with LVNC and LV hyp

189 bacteremia were included, all examined using echocardiography, including transesophageal echocardiogr

190 Doppler echocardiography is a well-recognized technique for the

191 predictor of mortality in human patients and echocardiography is an important tool in monitoring resp

192 LV thrombus detected by LGE CMR but not by echocardiography is associated with a similar risk of em

193 dysfunction with conventional 2-dimensional echocardiography is challenging, whereas speckle-trackin

194 Contrast echocardiography is extremely sensitive, but not specifi

195 Echocardiography is routinely used for screening of morp

196 Echocardiography is the recommended first-line test for

197 s measured noninvasively using transthoracic echocardiography, is associated with higher mortality in

198 This model is based on conventional echocardiography, is easy to apply, and is, therefore, s

199 y of Echocardiograms From Public and Private Echocardiography Laboratories From Around Australia, Lin

200 to II patients with HFpEF underwent standard echocardiography, lung ultrasound (28-scanning point met

201 The prognostic power of CMR beyond echocardiography-LVEF was assessed using adjusted C stat

202 Most patients displayed echocardiography-LVEF>=50% (629, 56%), and they had a lo

203 provement index, 0.10) but not in those with echocardiography-LVEF>=50% (C statistic 0.66 versus 0.66

204 ACE prediction in the group of patients with echocardiography-LVEF<50% (C statistic, 0.80 versus 0.72

205 In patients with echocardiography-LVEF<50% (n=490, 44%), the MACE rate wa

206 levation myocardial infarction patients with echocardiography-LVEF<50% can provide insights into pati

207 In the entire group, CMR-LVEF (but not echocardiography-LVEF) independently predicted MACE occu

208 Compared with echocardiography-LVEF, CMR-LVEF significantly improved M

209 i.p.) would decrease cardiac output at rest (echocardiography), maximal aerobic capacity ( V O(2) max

210 Echocardiography may be a valuable diagnostic and progno

211 None of the echocardiography measurements correlated with cardiac fu

212 s (24-hrs) and 1-Month (1-M) after exposure, echocardiography, micro-positron emission tomography(u-P

213 al clues provided by electrocardiography and echocardiography might not be typical.

214 Cardiac remodeling was evaluated by serial echocardiography, morphometric analysis, and histology.

215 = 0.015), faster hemodynamic progression on echocardiography (n = 129; 0.23 +/- 0.20 m/s/year vs. 0.

216 Echocardiography normalized in 62 patients (75%) within

217 agreed toolbox, which contains protocols for echocardiography, novel object recognition, grip strengt

218 Echocardiography only detected mild chamber remodelling

219 No significant changes in echocardiography or cardiac biomarkers after RT were fou

220 measuring left ventricular mass index using echocardiography or cardiovascular magnetic resonance, b

221 ography scan, magnetic resonance imaging, or echocardiography) or between modalities.

222 us patients with LV thrombus not detected by echocardiography (P=0.25).

223 sus 0% if OAC at the time of transesophageal echocardiography, P=0.151).

224 regression models incorporating conventional echocardiography parameters demonstrated LA strain and S

225 The mean number of echocardiographies performed was 3+/-1.2 per patient.

226 Echocardiography performed 4 weeks post-MI showed that P

227 Echocardiography post-transcatheter aortic valve replace

228 ic, severe aortic stenosis and transthoracic echocardiography pre- and post-transcatheter aortic valv

229 Disease progression was monitored by echocardiography prior to MU by hHTx/MU.

230 cardiac remodeling and function after MI by echocardiography, quantitative immunohistochemistry, and

231 for identifying diastolic dysfunction before echocardiography remain imprecise.

232 Echocardiographic assessment of LVDD by echocardiography remains a challenging task; recent reco

233 , IE diagnosis always poses a challenge, and echocardiography remains diagnostically imperfect in cas

234 Echocardiography remains the preferred technique for ass

235 or foreign body materials present), a normal echocardiography result, and (18)F-FDG PET/CT without si

236 Echocardiography revealed increased LV dilatation, alter

237 Echocardiography revealed that banding induced concentri

238 absence of diastolic dysfunction criteria at echocardiography ruled out the risk of further cardiac d

239 phy is challenging, whereas speckle-tracking echocardiography RV free wall longitudinal strain has be

240 d effect in patients with the highest stress echocardiography score (P(interaction)=0.031).

241 able to detect an interaction between stress echocardiography score and any other patient-reported re

242 re (P(interaction)=0.789), or between stress echocardiography score and physician-assessed Canadian C

243 interaction between prerandomization stress echocardiography score and the effect of PCI on angina f

244 The stress echocardiography score is broadly the number of segments

245 d the ability of the prerandomization stress echocardiography score to predict the placebo-controlled

246 At prerandomization, the stress echocardiography score was 1.56+/-1.77 in the PCI arm (n

247 A positive agitated saline contrast echocardiography score was associated with anatomical sh

248 Echocardiography screening based on World Heart Federati

249 with E. faecalis bacteremia, suggesting that echocardiography should be considered in all patients wi

250 onins was 820 ng/L (normal, <13 ng/L), while echocardiography showed a normal left ventricular ejecti

251 Between 6 months and baseline, echocardiography showed average reductions of annular se

252 Two-dimensional echocardiography showed normal intracardiac connections,

253 Echocardiography showing decreased myocardial function i

254 oagulation if pre-procedural transesophageal echocardiography shows good device position, absence of

255 Speckle tracking echocardiography (STE), and more recently, cardiovascula

256 Imaging techniques such as contrast echocardiography suggest that anatomical intra-pulmonary

257 logical and electrophysiological function by echocardiography, surface ECG and conscious telemetry, i

258 A Doppler echocardiography systolic pulmonary artery pressure grea

259 tions between cardiac CT and transesophageal echocardiography (TEE) findings and adverse outcomes aft

260 ver the last decade, focused transesophageal echocardiography (TEE) has been proposed as a tool that

261 espite the widespread use of transesophageal echocardiography (TEE) to guide structural cardiac inter

262 likely to have evidence of cardiomyopathy on echocardiography than those reclassified as variants of

263 s part of her work-up, she underwent routine echocardiography that showed a normal heart but incident

264 At echocardiography, the anterior mitral leaflet was longer

265 alysis-induced ischemic injury, we also used echocardiography to assess intradialytic myocardial stun

266 PEX referred to undergo chest CT and stress echocardiography to evaluate surgical candidacy and/or t

267 These measures strengthen the ability of echocardiography to identify and follow pediatric PH pat

268 Using echocardiography to measure cardiac function, it was rev

269 ged 48.4+/-5.1 years) received 2-dimensional echocardiography to quantify relative wall thickness, LV

270 By transesophageal echocardiography, total MR was reduced to <= trivial in

271 d, for example, number of scans required for echocardiography training ranged from 10 to 100.

272 Systematic contrast transthoracic echocardiography (TTE) and cerebral magnetic resonance i

273 Focused transthoracic echocardiography (TTE) during cardiac arrest resuscitati

274 In 35 cases (72%), transthoracic echocardiography (TTE) identified a valvular lesion of a

275 four patients selected after transesophageal echocardiography underwent balloon interrogation with mo

276 lowed by modality (CT, MRI, nuclear imaging, echocardiography, US, radiography).

277 [76%] of 776 vs 538 [59%] of 915; p<0.0001), echocardiography use (442 [57%] of 776 vs 305 [33%] of 9

278 patients, we simultaneously recorded Doppler echocardiography variables (including tricuspid regurgit

279 s with LV thrombus that was also detected by echocardiography versus patients with LV thrombus not de

280 tery systolic pressure (PASP) estimated from echocardiography was categorized as substantially increa

281 monary artery pressure estimation by Doppler echocardiography was identified and outcomes were analyz

282 Echocardiography was performed a median of 2.1 years lat

283 Methods Echocardiography was performed at 2 institutions in 78 p

284 Transthoracic echocardiography was performed at baseline and after 18

285 Echocardiography was performed at rest, under anesthesia

286 At the fifth clinical examination, echocardiography was performed.

287 Herein, longitudinal echocardiography was used to assess whether NOD.Cg-Prkdc

288 Two-dimensional echocardiography was used to determine cardiac function

289 Echocardiography was used to determine the structure and

290 Using transthoracic echocardiography we measured f(H), and stroke volume (SV

291 is (MS) undergoing rest and treadmill stress echocardiography, we assessed characteristics and factor

292 With high-speed microscopy and echocardiography, we show that reduced VIC formation cor

293 d the cavoatrial junction on transesophageal echocardiography were excluded.

294 ight heart catheterization and 3-dimensional echocardiography were performed while preload was manipu

295 Invasive hemodynamics and echocardiography were used to assess regional work by st

296 Echocardiography, Western blotting, qPCR, immunohistoche

297 e exposure to ionizing radiation, similar to echocardiography, which can be performed at the bedside.

298 as those assigned to selective use underwent echocardiography with or without CMR according to the cl

299 esidual shunt was evaluated by transthoracic echocardiography with saline contrast.

300 atients with LVSWI measured by transthoracic echocardiography within 1 day of CICU admission.